The rapid advancement of manufacturing technologies has positioned Low-Code platforms as a compelling alternative to traditional, full-scale Manufacturing Execution Systems (MES). These platforms offer faster implementation, greater flexibility, and lower costs, making them especially appealing in industries like pharma, where agility and compliance are paramount. This session will examine the advantages and challenges of Low-Code solutions versus full-scale MES platforms, explore hybrid deployment scenarios, and discuss essential aspects of governance, deployment, and maintenance in regulated environments. In this session, you will learn how to:

• Identify when and where hybrid solutions (combining Low-Code and MES) make sense in manufacturing operations.
• Leverage the respective advantages of Low-Code platforms while addressing limitations in complex manufacturing environments.
• Understand the critical governance requirements of Low-Code solutions to ensure compliance with industry regulations.
• Navigate the challenges of deploying and maintaining Low-Code solutions, especially in regulated environments like pharmaceuticals.